Ancient Viral DNA in the Human Genome Linked to Multiple Sclerosis and Amyotrophic Lateral Sclerosis Oct. 21, 2024 — New research has revealed a connection between ancient viral DNA embedded in ...

The goal of multiple sclerosis (MS) treatment is to slow or stop the immune system's attack on the nervous system. Though several new medications have been approved in recent years that are effective ...

DA: Perfect and untested in two starts, including KEE romp over Ferocious; speedy colt must break well from inside post.

Trainer: P. D'Amato Jockey: Irad Ortiz, Jr. Last Race: Debutante, DMR, 2nd DA: She's consistent but just hasn't progressed much since early in 2YO season; this will be her first route attempt.

Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative ...

More information: Bruno Fautrel et al, EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's ...

If you've been diagnosed with multiple sclerosis (MS), it's time to start exploring treatment options. You've got a lot of them, everything from disease-modifying therapies and drugs that help manage ...

Sep. 16, 2024 — People may not hop backward often, but a new study shows that having people hop backward on one leg can be a better way of measuring strength and recovery in the knee, as well as ...

Individuals 75 years of age and above with AAV are at a higher risk of end-stage renal disease, severe infection, and death.

Prilenia Therapeutics B.V., a biopharmaceutical company focused on developing novel therapeutics to treat neurodegenerative and neurodevelopmental diseases, today announced the presentation of five ...